5/15/2013

Sanofi and Regeneron Pharmaceuticals have started enrolling patients with moderate to severe rheumatoid polyarthritis for two late-stage trials of their experimental drug sarilumab. The partners intend to recruit 2,600 patients.

Full Story:
Yahoo

Related Summaries